Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Applied and Environmental Microbiology|December 1, 1981
Phosphorus-limited growth of a green alga and a blue-green algaD S Lang, E J Brown
Toxicology|March 16, 2001
Effects of crocidolite asbestos on human bronchoepithelial-dependent fibroblast stimulation in coculture: the role of IL-6 and GM-CSFD S Lang, H Schocker, S Hockertz
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|November 1, 1993
Comparative effects of immunotoxic chemicals on in vitro proliferative responses of human and rodent lymphocytesD S Lang, K L Meier, M I Luster
Microbial Ecology|November 15, 2013
Competition between heterotrophic and autotrophic microplankton for dissolved nutrientsE J Brown, D K Button, D S Lang
Toxicology Letters|November 1, 1996
2,3,7,8-TCDD induces cytochrome P450 enzyme activity but not proliferation or phenotypical changes in human peripheral blood lymphocytesD S Lang, S Becker, R B Devlin, et al.
Cell Biology and Toxicology|April 16, 1998
Cell-specific differences in the susceptibility of potential cellular targets of human origin derived from blood and lung following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)D S Lang, S Becker, R B Devlin, et al.
Toxicology Letters|November 20, 1998
Interactions between human bronchoepithelial cells and lung fibroblasts after ozone exposure in vitroD S Lang, R A Jörres, M Mücke, et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|July 14, 2006
The HOPE technique opens up a multitude of new possibilities in pathologyE Vollmer, J Galle, D S Lang, et al.
Archives of Toxicology|January 1, 1994
Lack of direct immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human peripheral blood lymphocyte subsets in vitroD S Lang, S Becker, G C Clark, et al.
Breast (Edinburgh, Scotland)|January 22, 2013
Optimized immunohistochemistry in combination with image analysis: a reliable alternative to quantitative ELISA determination of uPA and PAI-1 for routine risk group discrimination in breast cancerD S Lang, U Heilenkötter, W Schumm, et al.
Pageof 2